 | |
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C19H24O3 |
| Molar mass | 300.398 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Pirnabine (SP-304) is a syntheticcannabinoid receptor ligand, which was developed for the treatment ofglaucoma.[1]
| Receptor (ligands) |
| ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Transporter (modulators) |
| ||||||||||||||||||||||||||||||
| Enzyme (modulators) |
| ||||||||||||||||||||||||||||||
| Others |
| ||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||
 | Thiscannabinoid related article is astub. You can help Wikipedia byexpanding it. |
